Since NF-κB is expressed not only in PDAC but also the various cell types constituting the tumor inflammatory milieu, targeting of NF-κB, therefore should be directed at balancing overall NF-κB signaling within the whole tumor microenvironment. This evidence concerns the gene NFKB1 and neoplasm.